Repligen Corporation (RGEN)
NASDAQ: RGEN · Real-Time Price · USD
164.98
-0.78 (-0.47%)
At close: Dec 5, 2025, 4:00 PM EST
161.80
-3.18 (-1.93%)
After-hours: Dec 5, 2025, 7:46 PM EST
Repligen Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Repligen stock have an average target of 170.9, with a low estimate of 135 and a high estimate of 204. The average target predicts an increase of 3.59% from the current stock price of 164.98.
Analyst Consensus: Buy
* Price targets were last updated on Oct 29, 2025.
Analyst Ratings
The average analyst rating for Repligen stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 2 | 1 | 2 | 2 |
| Buy | 5 | 6 | 6 | 6 | 6 | 6 |
| Hold | 4 | 4 | 4 | 3 | 3 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 10 | 11 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $150 → $165 | Hold | Maintains | $150 → $165 | +0.01% | Oct 29, 2025 |
| Barclays | Barclays | Buy Maintains $160 → $175 | Buy | Maintains | $160 → $175 | +6.07% | Oct 29, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $155 → $175 | Buy | Maintains | $155 → $175 | +6.07% | Oct 7, 2025 |
| Barclays | Barclays | Buy Maintains $150 → $160 | Buy | Maintains | $150 → $160 | -3.02% | Oct 2, 2025 |
| HSBC | HSBC | Strong Buy Initiates $150 | Strong Buy | Initiates | $150 | -9.08% | Oct 1, 2025 |
Financial Forecast
Revenue This Year
747.63M
from 634.44M
Increased by 17.84%
Revenue Next Year
841.63M
from 747.63M
Increased by 12.57%
EPS This Year
1.70
from -0.46
EPS Next Year
2.12
from 1.70
Increased by 24.46%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 771.3M | 889.5M | ||||
| Avg | 747.6M | 841.6M | ||||
| Low | 714.7M | 778.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 21.6% | 19.0% | ||||
| Avg | 17.8% | 12.6% | ||||
| Low | 12.7% | 4.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 1.79 | 2.39 | ||||
| Avg | 1.70 | 2.12 | ||||
| Low | 1.62 | 1.72 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | 40.3% | ||||
| Avg | - | 24.5% | ||||
| Low | - | 1.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.